RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases

Lung cancer is the leading cause of cancer-related mortality worldwide, and its tumorigenesis involves the accumulation of genetic and epigenetic events in the respiratory epithelium. Epigenetic modifications, such as DNA methylation, RNA modification, and histone modifications, have been widely reported to play an important role in lung cancer development and in other pulmonary diseases. Whereas the functionality of DNA and chromatin modifications referred to as epigenetics is widely characterized, various modifications of RNA nucleotides have recently come into prominence as functionally important. N6-methyladosine (m6A) is the most prevalent internal modification in mRNAs, and its machinery of writers, erasers, and readers is well-characterized. However, several other nucleotide modifications of mRNAs and various noncoding RNAs have also been shown to play an important role in the regulation of biological processes and pathology. Such epitranscriptomic modifications play an important role in regulating various aspects of RNA metabolism, including transcription, translation, splicing, and stability. The dysregulation of epitranscriptomic machinery has been implicated in the pathological processes associated with carcinogenesis including uncontrolled cell proliferation, migration, invasion, and epithelial-mesenchymal transition. In recent years, with the advancement of RNA sequencing technology, high-resolution maps of different modifications in various tissues, organs, or disease models are being constantly reported at a dramatic speed. This facilitates further understanding of the relationship between disease development and epitranscriptomics, shedding light on new therapeutic possibilities. In this review, we summarize the basic information on RNA modifications, including m6A, m1A, m5C, m7G, pseudouridine, and A-to-I editing. We then demonstrate their relation to different kinds of lung diseases, especially lung cancer. By comparing the different roles RNA modifications play in the development processes of different diseases, this review may provide some new insights and offer a better understanding of RNA epigenetics and its involvement in pulmonary diseases.

[1]  Yongyu Wang,et al.  Critical role of VGLL4 in the regulation of chronic normobaric hypoxia‐induced pulmonary hypertension in mice , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Shuyuan Liu,et al.  METTL3-mediated m6A modification of Bcl-2 mRNA promotes non-small cell lung cancer progression , 2021, Oncology reports.

[3]  X. Zhang,et al.  Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. , 2021, Free radical biology & medicine.

[4]  Xiaohong Wang,et al.  m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis , 2021, Journal of Hematology & Oncology.

[5]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[6]  H. Cui,et al.  Aberrant NSUN2-mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma , 2020, Oncogene.

[7]  Xinwei Huang,et al.  m6A RNA methylation regulators could contribute to the occurrence of chronic obstructive pulmonary disease , 2020, Journal of cellular and molecular medicine.

[8]  Fangwei Li,et al.  m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma , 2020, Frontiers in Genetics.

[9]  Wenke Liu,et al.  Large-scale transcriptome analysis identified RNA methylation regulators as novel prognostic signatures for lung adenocarcinoma , 2020, Annals of translational medicine.

[10]  Chang-Ping Hu,et al.  MEIS1 regulated proliferation and migration of pulmonary artery smooth muscle cells in hypoxia-induced pulmonary hypertension. , 2020, Life sciences.

[11]  Yusheng Zhang,et al.  Methyltransferase-like 1 (METTL1) served as a tumor suppressor in colon cancer by activating 7-methyguanosine (m7G) regulated let-7e miRNA/HMGA2 axis. , 2020, Life sciences.

[12]  Xue Leng,et al.  Contributions and prognostic values of m6A RNA methylation regulators in non‐small‐cell lung cancer , 2020, Journal of cellular physiology.

[13]  R. Sun,et al.  Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma , 2020, Medical science monitor : international medical journal of experimental and clinical research.

[14]  T. Tsukahara,et al.  The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB. , 2020, Biochemical and biophysical research communications.

[15]  K. Ying,et al.  Transcriptome-wide map of m6A circRNAs identified in a rat model of hypoxia mediated pulmonary hypertension , 2019, BMC Genomics.

[16]  C. Shan,et al.  YTH domain family 2 promotes lung cancer cell growth by facilitating 6-phosphogluconate dehydrogenase mRNA translation. , 2020, Carcinogenesis.

[17]  W. Ji,et al.  ALKBH5-m6A-FOXM1 signaling axis promotes proliferation and invasion of lung adenocarcinoma cells under intermittent hypoxia. , 2020, Biochemical and biophysical research communications.

[18]  Yang Liu,et al.  Overexpressed methyltransferase-like 1 (METTL1) increased chemosensitivity of colon cancer cells to cisplatin by regulating miR-149-3p/S100A4/p53 axis , 2019, Aging.

[19]  Hongsheng Wang,et al.  N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1 , 2019, Molecular Cancer.

[20]  Xiaohong Wang,et al.  m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis , 2019, Journal of Hematology & Oncology.

[21]  Joshua D. Jones,et al.  Pseudouridinylation of mRNA coding sequences alters translation , 2019, Proceedings of the National Academy of Sciences.

[22]  Zi-Zhen Zhang,et al.  METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer , 2019, Molecular Cancer.

[23]  Jun Chen,et al.  METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN , 2019, Journal of Molecular Medicine.

[24]  J. Luk,et al.  A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS , 2019, eLife.

[25]  C. Cho,et al.  m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer , 2019, Translational oncology.

[26]  W. Gilbert,et al.  mRNA structure determines modification by pseudouridine synthase 1 , 2019, Nature Chemical Biology.

[27]  Andrew J. Bannister,et al.  METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation , 2019, Molecular cell.

[28]  Jichang Li,et al.  METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway , 2019, Front. Pharmacol..

[29]  Yi Han,et al.  The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA. , 2019, Biochemical and biophysical research communications.

[30]  Chuan He,et al.  RETRACTED ARTICLE: RNA m6A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail , 2019, Nature Communications.

[31]  A. Herbert.  ADAR and Immune Silencing in Cancer. , 2019, Trends in cancer.

[32]  Qinghua Zhou,et al.  Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing , 2019, Front. Pharmacol..

[33]  A. Tackett,et al.  An N6‐methyladenosine at the transited codon 273 of p53 pre‐mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells , 2019, Biochemical pharmacology.

[34]  M. Bohnsack,et al.  Eukaryotic 5-methylcytosine (m5C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease , 2019, Genes.

[35]  S. Chambers,et al.  Human ALKBH3-induced m1A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells. , 2019, Biochimica et Biophysica Acta. Gene Regulatory Mechanisms.

[36]  Zhike Lu,et al.  Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs , 2018, Nucleic acids research.

[37]  J. Tainer,et al.  RNA Modifications: Reversal Mechanisms and Cancer. , 2018, Biochemistry.

[38]  A. Lusser,et al.  The dynamic RNA modification 5‐methylcytosine and its emerging role as an epitranscriptomic mark , 2018, Wiley interdisciplinary reviews. RNA.

[39]  A. Tewari,et al.  Predictive value of pseudouridine in prostate cancer. , 2019, American journal of clinical and experimental urology.

[40]  John G Doench,et al.  Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade , 2018, Nature.

[41]  Chie Tomikawa.  7-Methylguanosine Modifications in Transfer RNA (tRNA) , 2018, International journal of molecular sciences.

[42]  D. Takai,et al.  Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma , 2018, Cancer science.

[43]  Kwok-Kin Wong,et al.  mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis , 2018, Nature.

[44]  Ying Jin,et al.  m6A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression. , 2018, Biochemical and biophysical research communications.

[45]  M. Bohnsack,et al.  The m6A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5′–3′ exoribonuclease XRN1 , 2018, RNA.

[46]  T. Takayama,et al.  AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer. , 2018, JCI insight.

[47]  M. Bohnsack,et al.  Modifications in small nuclear RNAs and their roles in spliceosome assembly and function , 2018, Biological chemistry.

[48]  S. Pascolo,et al.  Epitranscriptomics of cancer , 2018, World journal of clinical oncology.

[49]  Chi Zhang,et al.  Reversible RNA Modification N1-methyladenosine (m1A) in mRNA and tRNA , 2018, Genom. Proteom. Bioinform..

[50]  L. Montanaro,et al.  Turning Uridines around: Role of rRNA Pseudouridylation in Ribosome Biogenesis and Ribosomal Function , 2018, Biomolecules.

[51]  Yinsheng Wang,et al.  Identification of YTH Domain-Containing Proteins as the Readers for N1-Methyladenosine in RNA. , 2018, Analytical chemistry.

[52]  Yu-Sheng Chen,et al.  Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism , 2018, Cell Research.

[53]  Z. Dauter,et al.  Structural insights into the RNA methyltransferase domain of METTL16 , 2018, Scientific Reports.

[54]  Mark Helm,et al.  Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the m6A machinery component Wtap/Fl(2)d , 2018, Genes & development.

[55]  Chuan He,et al.  VIRMA mediates preferential m6A mRNA methylation in 3′UTR and near stop codon and associates with alternative polyadenylation , 2018, Cell Discovery.

[56]  P. Sergiev,et al.  Structural and evolutionary insights into ribosomal RNA methylation. , 2018, Nature chemical biology.

[57]  Han Liang,et al.  The role of A-to-I RNA editing in cancer development. , 2018, Current opinion in genetics & development.

[58]  Stefan Hüttelmaier,et al.  Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation , 2018, Nature Cell Biology.

[59]  Jens Lagergren,et al.  ADARs and editing: The role of A-to-I RNA modification in cancer progression. , 2017, Seminars in cell & developmental biology.

[60]  M. Bühler,et al.  Zc 3 h 13 / Flacc is required for adenosine methylation by bridging the mRNA binding factor Rbm 15 / Spenito to the m 6 A machinery component Wtap / Fl ( 2 ) , 2018 .

[61]  Henning Urlaub,et al.  Human METTL16 is a N6‐methyladenosine (m6A) methyltransferase that targets pre‐mRNAs and various non‐coding RNAs , 2017, EMBO reports.

[62]  Rong Yin,et al.  Roles of RNA methylation by means of N6-methyladenosine (m6A) in human cancers. , 2017, Cancer letters.

[63]  Ravi Sachidanandam,et al.  Regulation of m6A Transcripts by the 3'→5' RNA Helicase YTHDC2 Is Essential for a Successful Meiotic Program in the Mammalian Germline. , 2017, Molecular cell.

[64]  David R. Jones,et al.  The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK , 2017, Science Signaling.

[65]  Howard Y. Chang,et al.  The conserved RNA helicase YTHDC2 regulates the transition from proliferation to differentiation in the germline , 2017, eLife.

[66]  Lingeng Lu,et al.  Association of tRNA methyltransferase NSUN2/IGF-II molecular signature with ovarian cancer survival. , 2017, Future oncology.

[67]  Chuan He,et al.  Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis , 2017, Cell Research.

[68]  K. Lau,et al.  RNA editing of AZIN1 induces the malignant progression of non-small-cell lung cancers , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[69]  ping wang,et al.  tRF‐Leu‐CAG promotes cell proliferation and cell cycle in non‐small cell lung cancer , 2017, Chemical biology & drug design.

[70]  Yang Xie,et al.  The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention , 2017, Cell.

[71]  M. Menezes,et al.  The LIN28/let-7 Pathway in Cancer , 2017, Front. Genet..

[72]  Zhike Lu,et al.  m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells , 2017, Cell reports.

[73]  K. Harada,et al.  AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells , 2017, Scientific Reports.

[74]  Olivier Elemento,et al.  Reversible methylation of m6Am in the 5′ cap controls mRNA stability , 2016, Nature.

[75]  Jie Jin,et al.  FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. , 2017, Cancer cell.

[76]  K. Entian,et al.  Tuning the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and function , 2016, RNA biology.

[77]  Wengong Wang,et al.  Overexpression of NSUN2 by DNA hypomethylation is associated with metastatic progression in human breast cancer , 2016, Oncotarget.

[78]  S. Jaffrey,et al.  Emerging links between m6A and misregulated mRNA methylation in cancer , 2017, Genome Medicine.

[79]  Nicolò Riggi,et al.  IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer , 2016, Genes & development.

[80]  Samie R. Jaffrey,et al.  m6A RNA methylation promotes XIST-mediated transcriptional repression , 2016, Nature.

[81]  Yitzhak Pilpel,et al.  Mitochondrial 16S rRNA Is Methylated by tRNA Methyltransferase TRMT61B in All Vertebrates , 2016, PLoS biology.

[82]  Ligang Wu,et al.  YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex , 2016, Nature Communications.

[83]  Ping Wang,et al.  Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. , 2016, Molecular cell.

[84]  Michaela Frye,et al.  Deficient methylation and formylation of mt-tRNAMet wobble cytosine in a patient carrying mutations in NSUN3 , 2016, Nature Communications.

[85]  G. B. Robb,et al.  mRNA capping: biological functions and applications , 2016, Nucleic acids research.

[86]  Chuan He,et al.  Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing. , 2016, Trends in genetics : TIG.

[87]  T. Preiss,et al.  METTL3 Gains R/W Access to the Epitranscriptome. , 2016, Molecular cell.

[88]  R. Gregory,et al.  The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells. , 2016, Molecular cell.

[89]  K. Myers,et al.  A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[90]  Chengqi Yi,et al.  Transcriptome-wide mapping reveals reversible and dynamic N(1)-methyladenosine methylome. , 2016, Nature chemical biology.

[91]  Chuanzhao Zhang,et al.  Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA , 2016, Proceedings of the National Academy of Sciences.

[92]  Meng-zhu Xue,et al.  Synergistic action of master transcription factors controls epithelial-to-mesenchymal transition , 2016, Nucleic acids research.

[93]  Samir Adhikari,et al.  Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing. , 2016, Molecular cell.

[94]  Bifeng Yuan,et al.  Determination of DNA and RNA Methylation in Circulating Tumor Cells by Mass Spectrometry. , 2016, Analytical chemistry.

[95]  K. Nishikura,et al.  A-to-I editing of coding and non-coding RNAs by ADARs , 2015, Nature Reviews Molecular Cell Biology.

[96]  F. Setién,et al.  Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis , 2015, Oncogene.

[97]  R. Weinberg,et al.  Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. , 2015, Trends in cell biology.

[98]  Leng Han,et al.  The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. , 2015, Cancer cell.

[99]  D. Lafontaine,et al.  'View From A Bridge': A New Perspective on Eukaryotic rRNA Base Modification. , 2015, Trends in biochemical sciences.

[100]  Shiqing Ma,et al.  Chemical pulldown reveals dynamic pseudouridylation of the mammalian transcriptome. , 2015, Nature chemical biology.

[101]  Huiyang Zhou,et al.  Genome-scale long noncoding RNA expression pattern in squamous cell lung cancer , 2015, Scientific Reports.

[102]  Chuan He,et al.  RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation , 2015, Genes & development.

[103]  Chuan He,et al.  N 6 -methyladenosine Modulates Messenger RNA Translation Efficiency , 2015, Cell.

[104]  A. Jeltsch,et al.  Somatic cancer mutations in the DNMT2 tRNA methyltransferase alter its catalytic properties. , 2015, Biochimie.

[105]  Erez Y. Levanon,et al.  m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation , 2015, Science.

[106]  M. Bohnsack,et al.  WBSCR22/Merm1 is required for late nuclear pre-ribosomal RNA processing and mediates N7-methylation of G1639 in human 18S rRNA , 2015, RNA.

[107]  K. Stenmark,et al.  The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[108]  Albert Kriegner,et al.  Methylation of ribosomal RNA by NSUN5 is a conserved mechanism modulating organismal lifespan , 2015, Nature Communications.

[109]  David Gacquer,et al.  Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome , 2015, bioRxiv.

[110]  Li Wang,et al.  Crystal structure of the YTH domain of YTHDF2 reveals mechanism for recognition of N6-methyladenosine , 2014, Cell Research.

[111]  Markus Blatter,et al.  Solution structure of the YTH domain in complex with N6-methyladenosine RNA: a reader of methylated RNA , 2014, Nucleic acids research.

[112]  Schraga Schwartz,et al.  Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites. , 2014, Cell reports.

[113]  T. Sio,et al.  Chemotherapeutic and targeted biological agents for metastatic bladder cancer: A comprehensive review , 2014, International journal of urology : official journal of the Japanese Urological Association.

[114]  Chuan He,et al.  Reading RNA methylation codes through methyl-specific binding proteins , 2014, RNA biology.

[115]  X Wang,et al.  Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer , 2014, Oncogene.

[116]  Yan Li,et al.  Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma. , 2014, Cancer research.

[117]  Samir Adhikari,et al.  Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase , 2014, Cell Research.

[118]  Miao Yu,et al.  A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation , 2013, Nature chemical biology.

[119]  M. Bohnsack,et al.  WBSCR 22 / Merm 1 is required for late nuclear pre-ribosomal RNA processing and mediates N 7-methylation of G 1639 in human 18 S rRNA , 2014 .

[120]  Makoto Naito,et al.  Identification of Wilms' Tumor 1-associating Protein Complex and Its Role in Alternative Splicing and the Cell Cycle* , 2013, The Journal of Biological Chemistry.

[121]  D. Dai,et al.  Promoter methylation and expression of TIMP3 gene in gastric cancer , 2013, Diagnostic Pathology.

[122]  Guifang Jia,et al.  Reversible RNA adenosine methylation in biological regulation. , 2013, Trends in genetics : TIG.

[123]  Arne Klungland,et al.  ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. , 2013, Molecular cell.

[124]  Leilei Chen,et al.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma , 2013, Nature Medicine.

[125]  E. Brzeziańska,et al.  The significance of epigenetic alterations in lung carcinogenesis , 2012, Molecular Biology Reports.

[126]  M. Kupiec,et al.  Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq , 2012, Nature.

[127]  R. Dumitrescu.  Epigenetic markers of early tumor development. , 2012, Methods in molecular biology.

[128]  K. Shimada,et al.  ALKBH 3 Contributes to Survival and Angiogenesis of Human Urothelial Carcinoma Cells through NADPH Oxidase and Tweak / Fn 14 / VEGF Signals , 2012 .

[129]  Chengqi Yi,et al.  N6-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO , 2011, Nature chemical biology.

[130]  Zdenko Herceg,et al.  Epigenetic mechanisms and cancer: An interface between the environment and the genome , 2011, Epigenetics.

[131]  K. Shimada,et al.  ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer , 2011, British Journal of Cancer.

[132]  Francesca Tuorto,et al.  RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage. , 2010, Genes & development.

[133]  Hiroki Kato,et al.  Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[134]  T. Mikkelsen,et al.  Altered adenosine-to-inosine RNA editing in human cancer. , 2007, Genome research.

[135]  Beverley Balkau,et al.  Variation in FTO contributes to childhood obesity and severe adult obesity , 2007, Nature Genetics.

[136]  F. Watt,et al.  The RNA Methyltransferase Misu (NSun2) Mediates Myc-Induced Proliferation and Is Upregulated in Tumors , 2006, Current Biology.

[137]  Mitsutoshi Nakamura,et al.  High Expression of a New Marker PCA-1 in Human Prostate Carcinoma , 2005, Clinical Cancer Research.

[138]  J. Yisraeli.  VICKZ proteins: a multi‐talented family of regulatory RNA‐binding proteins , 2005, Biology of the cell.

[139]  Pierre P Massion,et al.  The molecular basis of lung cancer: molecular abnormalities and therapeutic implications , 2003, Respiratory research.

[140]  M. Hendrix,et al.  Angiogenesis: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma , 2003, Nature Reviews Cancer.

[141]  E. Phizicky,et al.  Two proteins that form a complex are required for 7-methylguanosine modification of yeast tRNA. , 2002, RNA.

[142]  F. Rottman,et al.  Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei. Internal mRNA methylation requires a multisubunit complex. , 1994, The Journal of biological chemistry.

[143]  R J Roberts,et al.  Sequence specificity of the human mRNA N6-adenosine methylase in vitro. , 1990, Nucleic acids research.

[144]  Z W Gu,et al.  Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. , 1987, Science.

[145]  R. Pease,et al.  A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine , 1987, Cell.